Invitation to Roche ’s Half Year Results 2022 Webinar

   Roche will publish its Half Year Results of 2022 prior to the opening of the Swiss Stock Exchange onThursday, 21 July 2022.07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)Release will be e-mailed and posted on the Roche IR website>click herePresentation slides will be posted on the Roche IR website>click here14:00 – 15:30 CEST / 13:00 – 14:30 BST08:00 – 09:30 AM EDT / 05:00 - 06:30 AM PDTThe webinar will start with presentations by senior management,followed by a Q&A session.Presenters:Severin Schwan, CEO Roche GroupBill Anderson, CEO Roche PharmaceuticalsThomas Schinecker, CEO Roche Diagnostics  Alan Hippe, Chief Financial and IT Officer We would like to invite all interested parties to participate in the webinar and to pre-register for the eventhere.*Should you be unable to register for the webinar due to your company IT policy, please send an email toinvestor.relations@roche.com.A replay of the webinar will be available via>ir.roche.com*privacy notice   Best regards,  Bruno EschliHead of Investor Relations    Roche Investor Relations Dr. Bruno EschliPhone: +41 61 68-75284e-mail:bruno.eschli@roche.com Dr. Sabine Borngr äberPhone: +41 61 68-88027e-mail:sabine.borngraeber@roche.com Dr. Birgit MasjostPhone: +41 61 68-84814e-mail:birgit.masjost@roche.com Dr. Gerard TobinPhone: +41 61 68-72942e-mail:gerard.tobin@roche.com  Investor Relations North America Loren KalmPhone: +1 650 225 3217e-mail:kalm.loren@...
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news